Hyperglycemia management in the hospital: About glucose targets and process improvements

Postgraduate Medicine

Volumn 120, Issue 4, 2008, Pages 38-50

  Juneja, Rattan ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Basal bolus; Diabetes; Glycemic targets; Hyperglycemia; Inpatient; Insulin analogs

Indexed keywords

GLUCOSE; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; ANTIDIABETIC AGENT;

CONFUSION; CONTINUOUS INFUSION; DRUG SAFETY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE COST; HEALTH EDUCATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL MANAGEMENT; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; MEDICAL STAFF; OUTCOME ASSESSMENT; PHYSICIAN; REVIEW; BLOOD; CLINICAL PROTOCOL; HEALTH CARE QUALITY; HOSPITALIZATION; METABOLISM;

BLOOD GLUCOSE; CLINICAL PROTOCOLS; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; PROCESS ASSESSMENT (HEALTH CARE);

EID: 58149195611     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2008.11.1937     Document Type: Review

References (97)

1. Cook CB, Castro JC, Schmidt RE, et al. Diabetes care in hospitalized noncritically ill patients: More evidence for clinical inertia and negative therapeutic momentum. J Hosp Med. 2007;2(4):203-211. (Pubitemid 47377265)
2. Clement S, Braithwaite SS, Magee MF, et al. American Diabetes Association Diabetes in Hospitals Writing Committee. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27(2):553-591.
3. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978-982. (Pubitemid 36121050)
4. Beilman GJ, Joseph JI. Practical considerations for glucose control in hospitalized patients. Diabetes Technol Ther. 2005;7(5):823-830. (Pubitemid 41572092)
5. Conner TM, Flesner-Gurley KR, Barner JC. Hyperglycemia in the hospital setting: the case for improved control among non-diabetics. Ann Pharmacother. 2005;39(3):492-501. (Pubitemid 40270915)
6. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5):449-461. (Pubitemid 43200296)
7. Garber AJ, Moghissi ES, Bransome ED Jr, et al. American College of Endocrinology Task Force on Inpatient Diabetes Metabolic Control. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004;10(1):77-82.
8. Langley J, Adams G. Insulin-based regimens decrease mortality rates in critically ill patients: a systematic review. Diabetes Metab Res Rev. 2007;23(3):184-192. (Pubitemid 46437843)
9. Pomposelli JJ, Baxter JK 3rd, Babineau TJ, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients, JPEN J Parenter Enteral Nutr. 1998;22(2):77-81.
10. Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg. 1997;63(2):356-361. (Pubitemid 27084552)
11. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78(12):1471-1478. (Pubitemid 37475630)
12. Baker EH, Janaway CH, Philips BJ, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax. 2006;61(4):284-289.
13. Rady MY, Johnson DJ, Patel BM, Larson JS, Helmers RA. Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus. Mayo Clin Proc. 2005;80(12):1558-1567. (Pubitemid 41747057)
14. Levetan CS. Effect of hyperglycemia on stroke outcomes. Endocr Pract. 2004;10(Suppl 2):34-39.
15. Saint S, Kaufman SR, Rogers MA, Baker PD, Boyko EJ, Lipsky BA. Risk factors for nosocomial urinary tract-related bacteremia: a case-control study. Am J Infect Control. 2006;34(7):401-407. (Pubitemid 46059271)
16. Lepore G, Maglio ML, Cuni C, et al. Poor glucose control in the year before admission as a powerful predictor of amputation in hospitalized patients with diabetic foot ulceration. Diabetes Care. 2006;29(8):1985. (Pubitemid 44156671)
17. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol. 2002;40(10):1748-1754. (Pubitemid 35341952)
18. Ainla T, Baburin A, Teesalu R, Rahu M. The association between hyperglycaemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes. Diabet Med. 2005;22(10):1321-1325. (Pubitemid 41391305)
19. Gale SC, Sicoutris C, Reilly PM, Schwab CW, Gracias VH. Poor glycemic control is associated with increased mortality in critically ill trauma patients. Am Surg. 2007;73(5):454-460.
20. Pittas AG, Siegel RD, Lau J. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. Arch Intern Med. 2004;164(18):2005-2011. (Pubitemid 39390557)
21. Van den Berghe G, Wouters P, Weckers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359-1367.
22. Hein MD. Management of hyperglycemia in the hospitalized podiatric medical patient. J Am Podiatr Med Assoc. 2004;94(2):135-148. (Pubitemid 38469556)
23. Garber AJ. New standards to reduce morbidity and mortality in hospitalized patients with diabetes. Am Fam Physician. 2006;73(4):591-594. (Pubitemid 43275837)
24. Ahmann AJ. Inpatient management of hospitalized patients with type 2 diabetes. Curr Diab Rep. 2004;4(5):346-351. (Pubitemid 39480952)
25. Newton CA, Young S. Financial implications of glycemic control: results of an inpatient diabetes management program. Endocr Pract. 2006;12(suppl 3):43-48. (Pubitemid 44963592)
26. Olson L, Muchmore J, Lawrence CB. The benefits of inpatient diabetes care: improving quality of care and the bottom line. Endocr Pract. 2006;12(suppl 3):35-42. (Pubitemid 44963591)
27. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract. 2004;10(suppl 2):21-33.
28. Van den Berghe G, Wouters PJ, Kesteloot K, Hilleman DE. Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med. 2006;34(3):612-616. (Pubitemid 43308245)
29. Krinsley JS, Jones RL. Cost analysis of intensive glycemic control in critically ill adult patients. Chest. 2006;129(3):644-650.
30. Cohen MR, Kilo CM. In: Cohen MR, ed. Medication Errors. Washington, DC: American Pharmaceutical Association; 1999.
31. Joint Commission. Inpatient diabetes certification. http://www. jointcommission.org/CertificationPrograms/Inpatient+Diabetes. Accessed August 25, 2008.
32. Markovitz LJ, Wiechmann RJ, Harris N, et al. Description and evaluation of a glycemic management protocol for patients with diabetes undergoing heart surgery. Endocr Pract. 2002;8(1):10-18. (Pubitemid 34126686)
33. McDonough KA, DeWitt DE. Inpatient management of diabetes. Prim Care. 2003;30(3):557-567.
34. Moghissi E. Hospital management of diabetes: beyond the sliding scale. Cleve Clin J Med. 2004;71(10):801-808. (Pubitemid 39429639)
35. Moghissi ES, Hirsch IB. Hospital management of diabetes. Endocrinol Metab Clin North Am. 2005;34(1):99-116. (Pubitemid 40332505)
36. Trence DL, Kelly JL, Hirsch IB. The rationale and management of hyperglycemia for in-patients with cardiovascular disease: time for change. J Clin Endocrinol Metab. 2003;88(6):2430-2437. (Pubitemid 36724407)
37. Leahy JL. Insulin management of diabetic patients on general medical and surgical floors. Endocr Pract. 2006;12(suppl 3):86-90. (Pubitemid 44963599)
38. Goldberg PA, Siegel MD, Sherwin RS, et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004;27(2):461-467. (Pubitemid 38174072)
39. Eigsti J, Henke K. Innovative solutions: development and implementation of a tight blood glucose management protocol: one community hospital's experience. Dimens Crit Care Nurs. 2006;25(2):62-65.
40. DeSantis AJ, Schmeltz LR, Schmidt K, et al. Inpatient management of hyperglycemia: the Northwestern experience. Endocr Pract. 2006;12(5):491-505. (Pubitemid 46456036)
41. Beishuizen A, Groeneveld AB. Implementing strict glucose control: it is not that simple... Crit Care Med. 2006;34( 12):3050-3051. (Pubitemid 44808761)
42. Clayton SB, Mazur JE, Condren S, Hermayer KL, Strange C. Evaluation of an intensive insulin protocol for septic patients in a medical intensive care unit. Crit Care Med. 2006;34(12):2974-2978. (Pubitemid 44808740)
43. Devos P, Preiser JC. Current controversies around light glucose control in critically ill patients. Curr Opin Clin Nutr Metab Care. 2007;10(2):206-209. (Pubitemid 46220315)
44. Freire AX, Avecillas JF, Yataco JC, Freire NE. Hypoglycemia risk: a cause for concern in the intensive care unit hyperglycemia control debate. Crit Care Med. 2007;35(4):1222. (Pubitemid 46598996)
45. Thomas AN, Boxall EM, Twamley HW. Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med. 2007;35(4):1218-1219. (Pubitemid 46598990)
46. Ligtenbcrg JJ, Stemerdink A, Vogelzang M, Borggreve HF, Herngreen T, Zijlstra JG. Tight glucose control and hypoglycemia: should we bother? Crit Care Med. 2007;35(4):1218. (Pubitemid 46598989)
47. Preiser JC, Devos P. Clinical experience with tight glucose control by intensive insulin therapy. Crit Care Med. 2007;35(9 Suppl):S503-S507. (Pubitemid 47312186)
48. Gilman JA. A quality improvement project for better glycemic control in hospitalized patients with diabetes. Diabetes Educ. 2001;27(4):541-546. (Pubitemid 33614401)
49. Braithwaite SS, Buie MM, Thompson CL, et al. Hospital hypoglycemia: not only treatment but also prevention. Endocr Pract. 2004;10(suppl 2):89-99.
50. Bode BW, Braithwaite SS, Steed RD, Davidson PC. Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy. Endocr Pract. 2004;10(Suppl 2):71-80.
51. Hermansen K, Fontaine P, Kukolja KK, Peterkova V, Leth G, Gall MA. Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes. Diabetologia. 2004;47(4):622-629. (Pubitemid 38658363)
52. Vazquez-Carrera M, Silvestre JS. Insulin analogues in the management of diabetes. Methods Find Exp Clin Pharmacol. 2004;26(6):445-461. (Pubitemid 39079110)
53. Rosenstock J, Dailey G, Massi-Benedetti M, Fritsche A, Lin Z, Salzman A. Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes. Diabetes Care. 2005;28(4):950-955. (Pubitemid 40434505)
54. Home P, Kurtzhals P. Insulin detemir: from concept to clinical experience. Expert Opin Pharmacother. 2006;7(3):325-343. (Pubitemid 43263250)
55. Umpierrez GE, Smiley D, Zisman A, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007;30(9):2181-2186. (Pubitemid 47359011)
56. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA. 2003;290(15):2041-2047. (Pubitemid 37430587)
57. Haas LB. Optimizing insulin use in type 2 diabetes: role of basal and prandial insulin in long-term care facilities. J Am Med Directors Assoc. 2007;8(8):502-510. (Pubitemid 47532934)
58. Juneja R, Roudebush C, Kumar N, et al. Utilization of a computerized intravenous insulin infusion program to control blood glucose in the intensive care unit. Diabetes Technol Ther. 2007;9(3):232-240. (Pubitemid 46959788)
59. Laird AM, Miller PR, Kilgo PD, Meredith JW, Chang MC. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma. 2004;56(5):1058-1062. (Pubitemid 38788732)
60. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355(9206):773-778. (Pubitemid 30128815)
61. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32(10):2426-2432. (Pubitemid 32954818)
62. Williams R, Van Gaal L, Lucioni C. Assessing the impact of complications on the costs of Type II diabetes. Diabetologia. 2002;45(7):S13-S17. (Pubitemid 34762209)
63. Meece J. Pharmacoeconomic advantages of insulin analogs. US Pharm. 2006;31:HS42-HS50.
64. Brunton SA. Nocturnal hypoglycemia: answering the challenge with long-acting insulin analogs. MedGenMed. 2007;9(2):38. (Pubitemid 46812922)
65. Peterson GE. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir. Curr Med Res Opin. 2006;22(12):2613-2619. (Pubitemid 46048376)
66. Valensi P, Cosson E. Is insulin detemir able to favor a lower variability in the action of injected insulin in diabetic subjects? Diabetes Metabolism. 2005;31(4 pt 2):4S34-4S39. (Pubitemid 41376667)
67. Boyle PJ, Zrebiec J. Management of diabetes-related hypoglycemia. South Med J. 2007;100(2):183-194. (Pubitemid 46213762)
68. Klein O, Lynge J, Endahl L, Damholt B, Nosek L, Heise T. Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes. Diabetes Obes Metab. 2007;9(3):290-299. (Pubitemid 46502046)
69. NovoLog® (insulin aspart [rDNA origin] injection) [package insert]. Princeton, NJ: Novo Nordisk; March 14, 2008.
70. Humalog® (insulin lispro injection [rDNA origin]) [package insert]. Indianapolis, IN: Eli Lilly and Company; September 6, 2007.
71. Apidra® (insulin glulisine [rDNA origin] injection) [package insert]. Bridgewater, NJ: sanofi-aventis U.S. LLC; April 2007.
72. Nasraway SA Jr. Sitting on the horns of a dilemma: avoiding severe hypoglycemia while practicing tight glycemic control. Crit Care Med. 2007;35(10):2435-2437. (Pubitemid 47476250)
73. Juneja R. Roudebush C, Kumar N, et al. Utilization of a computerized intravenous insulin infusion program to control blood glucose in the intensive care unit. Diabetes Technol Ther. 2007;9(3):232-240. (Pubitemid 46959788)
74. Heatlie JM. Reducing insulin medication errors: evaluation of a quality improvement initiative. J Nurs Staff Dev. 2003;19(2):92-98.
75. LaSalle JR. New insulin analogs: insulin detemir and insulin glulisine. Pract Diabetology. 2006;25:34-44.
76. Kamal AD, Bain SC. Insulin glulisine: efficacy and safety compared with other rapid-acting insulin analogues. Expert Opin Drug Safety. 2007;6(1):5-7. (Pubitemid 46138603)
77. Daughterly KK. Review of insulin therapy. J Pharm Pract. 2004;17:10-19. (Pubitemid 38112657)
78. Heise T, Pieber TR. Towards peakless, reproducible and long-acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studies. Diabetes Obes Metab. 2007;9(5):648-659. (Pubitemid 47261846)
79. Abourizk NN, Vora CK, Verma PK. Inpatient diabetology. The new frontier. J Gen Intern Med. 2004;19(5 pt 1):466-471. (Pubitemid 38638909)
80. Achtmeyer CE, Payne TH, Anawall BD. Computer order entry system decreased use of sliding scale insulin regimens. Methods Inf Med. 2002;41(4):277-281. (Pubitemid 35177866)
81. Schoeffler JM, Rice DA, Gresham DG. 70/30 insulin algorithm versus sliding scale insulin. Ann Pharmacother. 2005;39(10):1606-1610. (Pubitemid 41393116)
82. Golighlly LK, Jones MA, Hamamura DH, Sfolpman NM, McDermott MT. Management of diabetes mellitus in hospitalized patients: efficiency and effectiveness of sliding-scale insulin therapy. Pharmacotherapy. 2006;26(10):1421-1432. (Pubitemid 44521727)
83. Queale WS, Seidler AJ, Brancati FL. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med. 1997;157(5):545-552. (Pubitemid 27102713)
84. Donihi AC, DiNardo MM, Devita MA, Korytkowski MT. Use of a standardized protocol to decrease medication errors and adverse events related to sliding scale insulin. Qual Saf Health Care. 2006;15(2):89-91.
85. Browning LA, Dumo P. Sliding-scale insulin: an antiquated approach to glycemic control in hospitalized patients. Am J Health Syst Pharm. 2004;61(15):1611-1614. (Pubitemid 39481406)
86. Ku SY, Sayre CA, Hirsch IB, Kelly JL. New insulin infusion protocol improves blood glucose control in hospitalized patients without increasing hypoglycemia. Jt Comm J Qual Patient Saf. 2005;31(3):141-147.
87. Hellman R. Patient safety and inpatient glycemic control: translating concepts into action. Endocr Pract. 2006;12(suppl 3):49-55. (Pubitemid 44963593)
88. Santell JP, Hicks RW, McMeekin J, Cousins DD. Medication errors: experience of the United States Pharmacopeia (USP) MEDMARX reporting system. J Clin Pharmacol. 2003;43(7):760-767. (Pubitemid 36759155)
89. Lien LF, Spratt SE, Woods Z, Osborne KK, Feinglos MN. Optimizing hospital use of intravenous insulin therapy: improved management of hyperglycemia and error reduction with a new nomogram. Endocr Pract. 2005;11(4):240-253.
90. Vigersky RA. Optimizing management of type 2 diabetes in hospitalized patients who are not critically ill. Diabetes Technol Ther. 2005;7:831-833. (Pubitemid 41572093)
91. Wild D, von Maltzahn R, Brohan E, Christensed T, Clauson P, Gonder-Frederick L. A critical review ofthe literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education. Patient Educ Couns. 2007;68(1):10-15. (Pubitemid 47126791)
92. 1e levels for diabetes case finding in hospitalized patients with hyperglycemia. Diabetes Care. 2003;26(4):1064-1068. (Pubitemid 36929249)
93. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109(3):433-438. (Pubitemid 38133916)
94. Korytkowski M, Niskanen L, Asakura T. FlexPen: addressing issues of confidence and convenience in insulin delivery. Clin Ther 2005;27(suppl B):S89-S100.
95. Korytkowski M. When oral agents fail: practical barriers to starting insulin. Int J Obes Relat Metab Disord. 2002;26(suppl 3):S18-S24. (Pubitemid 35034478)
96. Austin MM, Haas L, Johnson T, et al. Self-monitoring of blood glucose: benefits and utilization. Diabetes Educ. 2006;32(6):835-837.
97. Wheeler K, Crawford R, McAdams D, et al. Inpatient to outpatient transfer of care in urban patients with diabetes: patterns and determinants of immediate postdischargc follow-up. Arch Intern Med. 2004;164(4):447-453. (Pubitemid 38240711)